Jocund India Limited - pharma in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U74899DL1995PLC072290 Incorporated 08 September 1995 ROC Delhi HQ New Delhi, Delhi, India
Active Public Limited Company pharma MSME · Small
Data last updated
Revenue · FY 2024
₹13.26 Cr
▲ 3% YoY
Net profit · FY 2024
₹2.43 Cr
Net margin 18.3%
EBITDA · FY 2024
₹2.77 Cr
EBITDA margin 20.9%
Authorised capital
₹1.5 Cr
Registered with MCA
Paid-up capital
₹1.1 Cr
Issued & subscribed
Satisfied charges
₹7.33 Cr
No open charges
Company age
31 yrs
Est. 1995
Employees · EPFO
32
Provident fund records

About Jocund India Limited

Data last updated:

Jocund India Limited is a public limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 September 1995 and has been in existence for over 31 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74899DL1995PLC072290. Its GSTIN is 05AAACJ3148F1ZY (Uttarakhand).

The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.1 Cr. It is led by directors including Chhavi Prakash Singhal (Whole-Time Director) and Saurabh Gupta.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Second Floor 2C/7 New Rohtak Road, Near Liberty Cinema Karol Bagh, New Delhi, Delhi, India – 110005.

As per the financials filed for FY 2024, the company reported a revenue of ₹13.26 Cr, a growth of 3% compared to the previous year. For the same year it recorded a net profit of ₹2.43 Cr (net margin 18.3%) and EBITDA of ₹2.77 Cr (EBITDA margin 20.9%). Revenue has grown at a compounded annual rate (CAGR) of 13% over three years and 6% over five years.

The company has about 32 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Jocund India. As per MCA filings, the company has satisfied charges of ₹7.33 Cr on record. Court records list 7 cases involving the company, including 3 filed by the company and 4 filed against it; 4 cases are pending.

Jocund India Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-01-0005353). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jocundindia.com.

Company details

CIN U74899DL1995PLC072290
Registration Number 072290
Incorporation Date 08 September 1995
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-01-0005353

Recognitions & Rankings of Jocund India

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-DL-01-0005353

Contact details

Jocund India Limited's registered office is in New Delhi, Delhi. Its website is jocundindia.com. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Second Floor 2C/7 New Rohtak Road, Near Liberty Cinema Karol Bagh, New Delhi, Delhi, India – 110005
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Jocund India Limited, buy the company report.

Comprehensive company report
Jocund India Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Jocund India operates one associated brand: Jocund India. Each brand links to its own profile.

BrandDescriptionWebsite
Manufactures and exports tablets, capsules, injections, and syrups globally.jocundindia.com

Business activity

The main business activity of Jocund India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Jocund India Limited, buy the company report.

Financials of Jocund India Limited

FY 2025 filings available

Jocund India Limited reported revenue of ₹13.26 Cr (up 3% YoY) for FY 2024.

Revenue · FY 2024
₹13.26 Cr ▲ 3%
Net profit · FY 2024
₹2.43 Cr margin 18.3%
EBITDA · FY 2024
₹2.77 Cr margin 20.9%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 13%
5 years · compounded
▲ 6%
EBITDA CAGR growth
1 year
▲ 28%
3 years · compounded
▲ 16%
5 years · compounded
▲ 11%

Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 3% growth in the latest year. EBITDA rose 28% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹2.77 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹2.43 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin20.9%
Net Profit Margin18.3%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Jocund India Limited, buy the company report.

Board of directors of Jocund India Limited

Jocund India has 3 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Saurabh GuptaDirector08 Sep 199531 Years 1 MonthsCurrent
Chhavi Prakash SinghalWhole-Time Director15 Mar 20188 Years 7 MonthsCurrent
Rakesh Kumar GuptaDirector16 Mar 20206 Years 7 MonthsCurrent

Peer comparison

Jocund India Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Medoz Pharmaceuticals Private Limited₹13.36 Cr (FY 2025)6.0%Vadodara, Gujarat, India
Pharmacare Aura Private Limited₹13.33 Cr (FY 2025)64.0%Paonta Sahib, Himachal Pradesh, India
Burnet Pharmaceuticals Pvt Ltd₹13.28 Cr (FY 2024)26.0%Kolkata, West Bengal, India
Jocund India Limitedthis company₹13.26 Cr (FY 2024)₹2.43 Cr18.3%3.0%32New Delhi, Delhi, India
Genees Pharmaceutical Private Limited₹13.26 Cr (FY 2025)27.0%Pune, Maharashtra, India
Zinnia Life Sciences Private Limited₹13.25 Cr (FY 2025)74.0%Coimbatore, Tamil Nadu, India

To see the full peer comparison of Jocund India Limited, buy the company report.

Auditor

Jocund India Limited is audited by R SHARMA & ASSOCIATES for the financial year 2019.

Auditor firmFinancial yearFirm registration number
R SHARMA & ASSOCIATESFY 2019003683N

Shareholding

The shareholding of Jocund India Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Jocund India Limited, buy the company report.

Charges & borrowings

Open charges
None
Satisfied charges
₹7.33 Cr
Breakdown by lending institutions
Small Industries Development Bank of India₹4.33 Cr
Bank of India₹3.00 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
24 Aug 200710067114Small Industries Development Bank of India₹1.4 CrSatisfied
31 May 200610006409Bank of India₹1.5 CrSatisfied
15 May 200610006393Bank of India₹1.5 CrSatisfied
20 Oct 200580034207Small Industries Development Bank of India₹2.93 CrSatisfied

To see the full charge records of Jocund India Limited, buy the company report.

Total charge records: 4 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Jocund India Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Jocund India Limited has a workforce of 32 employees on its EPFO records as of Apr 05, 2024, across 1 active EPFO establishment.

Employee count
32
Active EPFO establishments
1
Employee growth
-8.57%

GST

Jocund India has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
05AAACJ3148F1ZYUttarakhandActive01 Jul 2017

To see the full GST registrations and return filing status of Jocund India Limited, buy the company report.

Recent activity

Jocund India Limited has 10 board changes on record since 1995: 3 appointments and 7 cessations. The latest: Rakesh Kumar Gupta ceased to be Additional Director on 31 Dec 2020.

AGM
Jocund India Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Jocund India Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Ceased
Rakesh Kumar Gupta ceased to be Additional Director.
Ceased
Vijay Kumar Gupta ceased to be Director.
Appointed
Rakesh Kumar Gupta was appointed as Director.
Ceased
Pramod Kumar Agarwal ceased to be Whole-Time Director.
Appointed
Chhavi Prakash Singhal was appointed as Whole-Time Director.
Ceased
Chhavi Prakash Singhal ceased to be Additional Director.
Ceased
Asit ceased to be Whole-Time Director.
Ceased
Kesri Nandan Rastogi ceased to be Whole-Time Director.
Ceased
Sudhir Gupta ceased to be Managing Director.
Charges
A charge registered on 24 Aug 2007 via Charge ID 10067114 with Small Industries Development Bank Of India was fully satisfied on 14 Jul 2011.

9 earlier events are in the company report.

Frequently asked questions

Jocund India is an active public limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 September 1995 (31+ years old) and is registered under CIN U74899DL1995PLC072290.

Jocund India has 3 current directors:

The latest financial statements of Jocund India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Jocund India is 05AAACJ3148F1ZY, registered in Uttarakhand.

The CIN (Corporate Identification Number) of Jocund India is U74899DL1995PLC072290. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Jocund India has 7 court cases on record: 3 filed by the company and 4 filed against it. 4 are pending. Most are in the high courts.

Jocund India was incorporated on 08 September 1995, making it 31+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Jocund India by revenue are Medoz Pharmaceuticals Private Limited, Pharmacare Aura Private Limited, Burnet Pharmaceuticals Pvt Ltd, Genees Pharmaceutical Private Limited, Zinnia Life Sciences Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Rakesh Kumar Gupta ceased to be Additional Director on 31 Dec 2020. Vijay Kumar Gupta ceased to be Director on 02 Apr 2020. Rakesh Kumar Gupta was appointed as Director on 16 Mar 2020. Jocund India has 10 board changes on record in total.

Yes, Jocund India is registered as a small enterprise under Udyam registration (number: UDYAM-DL-01-0005353).

Jocund India can be reached through the website jocundindia.com. Its registered office is in New Delhi, Delhi, India.